中欧医疗创新股票C(006229)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-1,583,779,244.53 |
-2,611,740,627.51 |
-3,353,336,647.74 |
-2,598,011,305.50 |
利息合计 |
6,347,666.95 |
3,505,639.43 |
5,971,507.37 |
2,758,166.36 |
其中:存款利息收入 |
2,602,559.39 |
1,247,016.52 |
2,911,407.52 |
1,554,893.12 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
3,745,107.56 |
2,258,622.91 |
3,060,099.85 |
1,203,273.24 |
投资收益合计 |
-2,724,525,881.89 |
-1,327,239,792.95 |
-2,394,241,852.78 |
-850,795,050.18 |
其中:股票投资收益 |
-2,802,557,260.52 |
-1,378,430,257.13 |
-2,484,870,935.51 |
-907,159,678.28 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
2,273,075.32 |
1,959,234.97 |
2,387,374.28 |
776,564.38 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
75,758,303.31 |
49,231,229.21 |
88,241,708.45 |
55,588,063.72 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
1,127,543,772.08 |
-1,290,135,467.83 |
-973,736,354.75 |
-1,755,893,775.83 |
其他收入 |
6,855,198.33 |
2,128,993.84 |
8,670,052.42 |
5,919,354.15 |
费用 |
133,775,273.96 |
69,749,056.77 |
228,594,970.23 |
129,012,235.26 |
管理人报酬 |
91,039,623.03 |
47,416,725.26 |
159,559,861.44 |
91,903,635.90 |
基金托管费 |
15,173,270.52 |
7,902,787.57 |
26,593,310.26 |
15,317,272.68 |
销售服务费 |
27,176,345.63 |
14,241,144.74 |
42,065,978.22 |
21,619,369.66 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
386,014.25 |
188,399.20 |
375,820.31 |
171,957.02 |
利润总额 |
-1,717,554,518.49 |
-2,681,489,684.28 |
-3,581,931,617.97 |
-2,727,023,540.76 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年